Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2015

01-06-2015 | Original Article

Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population

Authors: Daisuke Uchida, Hiroo Kawarazaki, Yugo Shibagaki, Takashi Yasuda, Naoto Tominaga, Tsuyoshi Watanabe, Koichi Asahi, Kunitoshi Iseki, Chiho Iseki, Kazuhiko Tsuruya, Kunihiro Yamagata, Toshiki Moriyama, Ichiei Narita, Shoichi Fujimoto, Tsuneo Konta, Masahide Kondo, Masato Kasahara, Kenjiro Kimura

Published in: Clinical and Experimental Nephrology | Issue 3/2015

Login to get access

Abstract

Background

It is not known if urine dipstick alone can identify chronic kidney disease (CKD) in the general Japanese population.

Methods

We designed a cross-sectional study using data obtained in 2008 from a nationwide community-based health examination program for adults aged 40–74. The data consisted of blood tests, urine tests and questionnaire related to metabolic disorders. Those who had both serum creatinine measured and urine dipstick tested were analyzed.

Results

Data were obtained from 538,846 people with a mean age of 62.8 years, consisting of 41.6 % males. Our study showed that 14.4 % had an eGFR below 60 mL/min/1.73 m2, 5.2 % had proteinuria and 18.1 % had CKD. Within the population with CKD, non-proteinuric CKD accounted for 71.4 %. The proportion of non-proteinuric CKD was highest in stage G3a (91.8 %) followed by G3b (77.0 %) disease, and was greater in the more elderly and in females. The proportion of non-proteinuric CKD was 47.9 % in diabetes mellitus, 69.3 % in dyslipidemia, 66.8 % in hypertension and 57.1 % in metabolic syndrome. Furthermore, non-proteinuric CKD accounted for 78.1 % of the population without these lifestyle diseases, suggesting that even in the population without apparent risk, CKD is still prevalent and can be missed when urine dipstick is the only screening method used.

Conclusions

This study showed that a considerable population of CKD might be overlooked when only dipstick proteinuria is assessed for CKD screening. Hence, we strongly recommend that both urinalysis and serum creatinine measurement should be a part of the nationwide CKD screening system.
Literature
1.
go back to reference Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef Imai E, Yamagata K, Iseki K, et al. Kidney disease screening program in Japan: history, outcome, and perspectives. Clin J Am Soc Nephrol. 2007;2:1360–6.PubMedCrossRef
2.
go back to reference Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men–the Tanno and Sobetsu Study. Hypertens Res Off J Jpn Soc Hypertens. 2005;28:203–8.CrossRef Takeuchi H, Saitoh S, Takagi S, et al. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men–the Tanno and Sobetsu Study. Hypertens Res Off J Jpn Soc Hypertens. 2005;28:203–8.CrossRef
3.
go back to reference Matsuzawa Y. Metabolic syndrome–definition and diagnostic criteria in Japan. J Atheroscler Thromb. 2005;12:301.PubMedCrossRef Matsuzawa Y. Metabolic syndrome–definition and diagnostic criteria in Japan. J Atheroscler Thromb. 2005;12:301.PubMedCrossRef
4.
go back to reference Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:982–92.CrossRef Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis Off J Natl Kidney Found. 2009;53:982–92.CrossRef
5.
go back to reference Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA J Am Med Assoc. 2010;303:423–9.CrossRef Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA J Am Med Assoc. 2010;303:423–9.CrossRef
6.
go back to reference Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081. Chronic Kidney Disease Prognosis Consortium, Matsushita K, van der Velde M et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081.
7.
go back to reference Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc. 2007;298:2038–47.CrossRef Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA J Am Med Assoc. 2007;298:2038–47.CrossRef
8.
go back to reference Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2010;80:17–28.PubMedCrossRef Levey AS, de Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2010;80:17–28.PubMedCrossRef
9.
go back to reference Muntner P. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529–38.PubMedCrossRef Muntner P. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005;16:529–38.PubMedCrossRef
10.
go back to reference Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res Off J Jpn Soc Hypertens. 2011;34:1106–10.CrossRef Nakayama M, Sato T, Miyazaki M, et al. Increased risk of cardiovascular events and mortality among non-diabetic chronic kidney disease patients with hypertensive nephropathy: the Gonryo study. Hypertens Res Off J Jpn Soc Hypertens. 2011;34:1106–10.CrossRef
11.
Metadata
Title
Underestimating chronic kidney disease by urine dipstick without serum creatinine as a screening tool in the general Japanese population
Authors
Daisuke Uchida
Hiroo Kawarazaki
Yugo Shibagaki
Takashi Yasuda
Naoto Tominaga
Tsuyoshi Watanabe
Koichi Asahi
Kunitoshi Iseki
Chiho Iseki
Kazuhiko Tsuruya
Kunihiro Yamagata
Toshiki Moriyama
Ichiei Narita
Shoichi Fujimoto
Tsuneo Konta
Masahide Kondo
Masato Kasahara
Kenjiro Kimura
Publication date
01-06-2015
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2015
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-014-1019-5

Other articles of this Issue 3/2015

Clinical and Experimental Nephrology 3/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.